ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
Modern Pathology2010Vol. 23(8), pp. 1061–1067
Citations Over TimeTop 1% of 2010 papers
Veit Scheble, Martin Braun, Rameen Beroukhim, Craig H. Mermel, Christian Ruiz, Theresia Wilbertz, Ann‐Cathrin Stiedl, Karen Petersen, Markus Reischl, Rainer Kuefer, David Schilling, Falko Fend, Glen Kristiansen, Matthew Meyerson, Mark A. Rubin, Lukas Bubendorf, Sven Perner
Related Papers
- → Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer(2008)96 cited
- → Frequency of PTEN alterations, TMPRSS2-ERG fusion and their association in prostate cancer(2015)15 cited
- → Clinical significance of ERG rearrangement subtype and its association with increased p53 expression in Japanese and German prostate cancer(2015)9 cited
- → ETS-TMPRSS2 fusion gene products in prostate cancer(2006)16 cited
- → Characterize the difference between TMPRSS2-ERG and non-TMPRSS2-ERG fusion patients by clinical and biological characteristics in prostate cancer(2018)3 cited